Clinical Trials Directory

Trials / Completed

CompletedNCT01550978

Evaluation of the Safety and Efficacy of the AnapnoGuard 100 System

The Safety of Using the AnapnoGuard 100 System in Intubated Critical Care Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Hospitech Respiration · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety of using the AnapnoGuard 100 system during the course of mechanical ventilation and intubation of critical care patients in Intensive Care Unit.

Conditions

Interventions

TypeNameDescription
DEVICEAnapnoGuard 100 SystemAnapnoGuard™ 100 Respiratory Guard System is intended for airway management by oral/nasal intubation while providing continuous endotracheal cuff pressure control using non-invasive measurement and monitoring of carbon dioxide concentration in the subglottic space and evacuation of secretions from above the endotracheal tube's cuff.

Timeline

Start date
2012-02-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2012-03-12
Last updated
2016-02-19

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01550978. Inclusion in this directory is not an endorsement.

Evaluation of the Safety and Efficacy of the AnapnoGuard 100 System (NCT01550978) · Clinical Trials Directory